Zactin Tabs shortage set to continue


TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues  Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s sponsor, Alphapharm says.   The Therapeutic Goods Administration (TGA) has announced that it has extended the Therapeutic Goods (Serious Scarcity and Substitutable Medicines) (Fluoxetine) Instrument

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Tasmania recognises its best
Next Research Roundup